[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20051654L - Forlenget frigjoring av farmasoytisk preparat - Google Patents

Forlenget frigjoring av farmasoytisk preparat

Info

Publication number
NO20051654L
NO20051654L NO20051654A NO20051654A NO20051654L NO 20051654 L NO20051654 L NO 20051654L NO 20051654 A NO20051654 A NO 20051654A NO 20051654 A NO20051654 A NO 20051654A NO 20051654 L NO20051654 L NO 20051654L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
prolonged release
cefkinoma
cefinoma
animals
Prior art date
Application number
NO20051654A
Other languages
English (en)
Other versions
NO334158B1 (no
Inventor
Peter Schmid
Alexander Boettner
Carsten Schmidt
Mark Allan
Carole Barbot
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20051654L publication Critical patent/NO20051654L/no
Publication of NO334158B1 publication Critical patent/NO334158B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytiske preparater med cefkinom i en bærer med forlenget frigjøring, omfattende en olje og aluminiumdistearat, gir forlenget varighet av effektive blodplasmakonsentrasjoner av cefkinom etter injeksjon i dyr.
NO20051654A 2002-10-25 2005-04-04 Farmasøytisk preparat med forlenget frigjøring, fremgangsmåte for fremstilling samt anvendelse for fremstilling av medikament for behandling av sykdom NO334158B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079477 2002-10-25
PCT/EP2003/011644 WO2004037265A1 (en) 2002-10-25 2003-10-20 Prolonged release pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO20051654L true NO20051654L (no) 2005-05-24
NO334158B1 NO334158B1 (no) 2013-12-23

Family

ID=32116298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051654A NO334158B1 (no) 2002-10-25 2005-04-04 Farmasøytisk preparat med forlenget frigjøring, fremgangsmåte for fremstilling samt anvendelse for fremstilling av medikament for behandling av sykdom

Country Status (18)

Country Link
EP (1) EP1558263B1 (no)
JP (1) JP4584715B2 (no)
CN (1) CN1326526C (no)
AR (1) AR041713A1 (no)
AT (1) ATE327759T1 (no)
AU (1) AU2003279302B2 (no)
BR (2) BRPI0315513B1 (no)
CA (1) CA2501395C (no)
CO (1) CO5700769A2 (no)
DE (1) DE60305728T2 (no)
ES (1) ES2265590T3 (no)
MX (1) MXPA05004219A (no)
NO (1) NO334158B1 (no)
NZ (1) NZ539478A (no)
PL (1) PL208585B1 (no)
PT (1) PT1558263E (no)
WO (1) WO2004037265A1 (no)
ZA (1) ZA200502956B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661099C (en) * 2006-08-30 2012-01-24 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
WO2009020744A1 (en) 2007-08-07 2009-02-12 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations comprising gdf-5 in aqueous acidic solution
CN102026619A (zh) 2008-04-14 2011-04-20 先进科技及再生医学有限责任公司 液体缓冲的gdf-5制剂
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
US9066864B2 (en) * 2011-01-12 2015-06-30 Intervet Inc. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法
CN117982413B (zh) * 2024-04-03 2024-06-18 山东恒邦中科生物工程有限公司 一种硫酸头孢喹肟注射液的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
GB9907916D0 (en) * 1999-04-07 1999-06-02 Takeda Chemical Industries Ltd Long-acting antibacterial composition
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Also Published As

Publication number Publication date
ES2265590T3 (es) 2007-02-16
PL376840A1 (pl) 2006-01-09
DE60305728D1 (de) 2006-07-06
CN1705483A (zh) 2005-12-07
CA2501395C (en) 2011-05-24
BR0315513A (pt) 2005-08-23
CA2501395A1 (en) 2004-05-06
PT1558263E (pt) 2006-10-31
JP2006510607A (ja) 2006-03-30
AU2003279302A1 (en) 2004-05-13
BRPI0315513B1 (pt) 2017-11-28
JP4584715B2 (ja) 2010-11-24
AU2003279302B2 (en) 2008-10-16
AR041713A1 (es) 2005-05-26
EP1558263B1 (en) 2006-05-31
CN1326526C (zh) 2007-07-18
WO2004037265A1 (en) 2004-05-06
MXPA05004219A (es) 2005-06-08
DE60305728T2 (de) 2006-10-12
EP1558263A1 (en) 2005-08-03
ZA200502956B (en) 2006-03-29
CO5700769A2 (es) 2006-11-30
ATE327759T1 (de) 2006-06-15
PL208585B1 (pl) 2011-05-31
NO334158B1 (no) 2013-12-23
NZ539478A (en) 2006-05-26

Similar Documents

Publication Publication Date Title
NO20051654L (no) Forlenget frigjoring av farmasoytisk preparat
ATE427747T1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
CY1109523T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
NO20062508L (no) Administrering av levodopa og karbidopa
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
DE60331153D1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
ITTO20020775A1 (it) Schienale di sedia.
NO20040968L (no) Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
LU92513I2 (fr) Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi)
LU92517I2 (fr) Delamanide et ses dérivés pharmaceutiquement acceptables
DK1487416T3 (da) Lægemiddelmikropartikler
ITPD20020138A1 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
EA200201252A1 (ru) Соединения, эффективные в качестве агонистов э2 - адренорецептора и ингибиторов фосфодиэстеразы pde4
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
AR046210A1 (es) Preparacion solida
DE60328978D1 (de) Isochinolinderivate als mao-b inhibitoren
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
DE60233891D1 (de) Selektives targeting von apoptotischen zellen
IS7492A (is) Lyfjablöndu uppskriftir, sem innifela melantónín
TR200501460T3 (tr) Onkolitik virüsler kullanarak ağrı azaltma yöntemi
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
ITTO20020867A1 (it) Schienale di sedia.
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter

Legal Events

Date Code Title Description
MK1K Patent expired